Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound

BenzingaDec 12 09:38 ET

EMA: Eli Lilly and Co (LLY.US) weight loss drug Mounjaro can also treat sleep apnea without the need for additional indications.

An expert panel of the EU pharmaceutical regulatory institution EMA has determined that Eli Lilly and Co's weight-loss drug Mounjaro does not require a separate indication for the treatment of obstructive sleep apnea (OSA).

Zhitong Finance08:34 ET

Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.

Barrons08:32 ET

Eli Lilly Gets Key European Backing for Omvoh in Crohn's Disease

WSJ08:32 ET

Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $994

Moomoo News08:31 ET · Ratings

Express News | Eli Lilly and Co - European Commission Decision on Omvoh Expected in Next 1-2 Months

Reuters08:13 ET